Medifast Unveils New Metabolic Health Research at ObesityWeek Conference
Medifast Inc. will present new metabolic health research at the ObesityWeek conference in Atlanta from November 4-7, 2025. The research includes studies on weight loss predictors, focusing on adherence and early intervention, highlighting Medifast's commitment to addressing metabolic dysfunction. The presentations are part of Medifast's ongoing scientific initiatives.
Medifast Inc. has announced the presentation of new research findings in metabolic health at the upcoming ObesityWeek conference, hosted by The Obesity Society in Atlanta, Georgia, from November 4-7, 2025. The Medifast Scientific and Clinical Affairs (S&CA) team will present two research studies, including one co-authored by Scientific Advisory Board member Dr. Jessica Unick, which explores predictors of weight loss with a focus on adherence and early intervention. These presentations highlight Medifast’s ongoing scientific initiatives and commitment to addressing metabolic dysfunction. The results are scheduled to be presented at the conference. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medifast Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251113536734) on November 13, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
